Range Low Price High Price Comment
30 days $4.71 $5.41 Tuesday, 30th Apr 2024 AUPH stock ended at $5.09. This is 1.60% more than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 4.02% from a day low at $4.98 to a day high of $5.18.
90 days $4.71 $8.49
52 weeks $4.71 $12.42

Historical Aurinia Pharmaceuticals Inc prices

Date Open High Low Close Volume
Feb 02, 2016 $2.11 $2.24 $2.11 $2.23 9 400
Feb 01, 2016 $2.07 $2.13 $2.02 $2.12 9 700
Jan 29, 2016 $2.07 $2.14 $2.00 $2.00 39 800
Jan 28, 2016 $2.11 $2.13 $2.09 $2.09 5 100
Jan 27, 2016 $2.17 $2.17 $2.05 $2.10 18 400
Jan 26, 2016 $2.15 $2.26 $2.10 $2.22 34 500
Jan 25, 2016 $2.21 $2.21 $2.09 $2.09 17 600
Jan 22, 2016 $1.98 $2.17 $1.95 $2.10 25 500
Jan 21, 2016 $1.88 $2.00 $1.76 $1.89 51 900
Jan 20, 2016 $1.70 $1.86 $1.50 $1.86 65 300
Jan 19, 2016 $1.81 $1.91 $1.73 $1.74 45 200
Jan 15, 2016 $1.98 $1.98 $1.42 $1.80 51 800
Jan 14, 2016 $2.11 $2.11 $1.96 $2.01 50 500
Jan 13, 2016 $2.24 $2.30 $2.10 $2.11 29 100
Jan 12, 2016 $2.35 $2.35 $2.19 $2.27 49 100
Jan 11, 2016 $2.42 $2.51 $2.24 $2.24 27 300
Jan 08, 2016 $2.55 $2.55 $2.41 $2.42 35 700
Jan 07, 2016 $2.65 $2.65 $2.45 $2.45 34 300
Jan 06, 2016 $2.69 $2.69 $2.57 $2.65 24 100
Jan 05, 2016 $2.51 $2.69 $2.44 $2.65 39 100
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT